Nkwụsị Benzodiazepine na mberede, ihe egwu ọdịdọ, na nlekọta mberede¶

Na-agbapụ na ndenye benzodiazepine kwa ụbọchị, ịnwe onye na-edepụta ọgwụ na-akwụsị n'ike n'ike, ma ọ bụ na-agbalị ịkwụsị ndenye ọgwụ dị elu ma ọ bụ benzodiazepines n'okporo ámá (** alprazolam / Xanax, clonazepam / Klonopin, lorazepam / Ativan, diazepam / Valium) ma ọ bụ broth broth. toki" n'ụlọ bụ nnukwu ihe mberede akwara ozi. Dị ka mmanya, benzodiazepines bụ ezigbo allosteric modulators nke ụbụrụ inhibitory \(\text{GABA}_\text{A}\) ion ion channels. Mgbe a na-ewere ya kwa ụbọchị maka ihe karịrị izu 3 ruo 6, usoro ụjọ ahụ na-agbadata n'ụzọ anụ ahụ ma na-eme ka ndị na-anabata GABA eke ya na-eme ka ọ bụrụ ihe na-akpali akpali ** glutamate (NMDA na AMPA) *** ndị na-anabata ya na ọwa calcium voltaji.

Ọ bụrụ na ebipụ benzodiazepine na mberede, ma ọ bụ ọbụna belata ngwa ngwa site na pasent 50, ụbụrụ na-efunahụ breeki na-egbochi kemịkal ya ebe ọkụ glutamate na-akpali akpali anaghị achịkwa ya. Dabere na mkpochapụ ọgwụ ahụ na ọkara ndụ, n'ime ** awa 12 ruo ụbọchị 10 ** mmadụ nwere ike ịga n'ihu site na oke ụjọ nlọghachi azụ, paresthesias anụ ahụ na-ere ọkụ, mmekpa ahụ anụ ahụ, na nhụsianya n'ime mberede ** n'ozuzu tonic-clonic convulsions, ọnọdụ epilepticus, catatonia, na delirium delirium. Nke kadị njọ, mmemme detox inpatient nke ụbọchị 5 ruo ụbọchị asaa nke na-ewepụ ndị ọrịa ngwa ngwa n'afọ nke benzodiazepines na-ebutekarị ọrịa ** Protracted Withdrawal Syndrome (BIND: Benzodiazepine-Induced Neurological Dysfunction)** na nnukwu akathisia igbu onwe. Ịmara mgbe ị ga-achọ nkwụsi ike Ngalaba Mberede ụlọ ọgwụ ozugbo, otu esi agbakọ ** Diazepam (Valium) Equivalence **, yana otu akaebe sitere na ** Ashton Manual na ASAM slow hyperbolic tapers ** na-echebe ụbụrụ gị na ndụ gị.

Mee nke a ugbu a¶

1. Kpọọ nọmba mberede nke mpaghara gị ma ọ bụ gaa na ngalaba mberede ụlọ ọgwụ kacha nso ozugbo ma ọ bụrụ na onye kwụsịrị ma ọ bụ belata benzodiazepines nwere ihe ọdịdọ, ọhụhụ, gbagwojuru anya, ma ọ bụ malite ịmị anụ ahụ na-enweghị nchịkwa. Kpọọ 911 na United States na Canada, 112 gafee European Union, 999 na United Kingdom, ma ọ bụ lelee anyị. nọmba mberede ndekọ.
2. ** Akwụsịla benzodiazepines kwa ụbọchị (ma ọ bụ ọgwụ Z dị ka zolpidem/Ambien, eszopiclone, ma ọ bụ zopiclone) na mberede "tuki oyi."*
3. ** Ọ bụrụ na ị gwụla benzodiazepine nke enyere gị aka na ngwụcha izu, ọgwụ efunahụ gị, ma ọ bụ nwee ụlọọgwụ dị nso na mberede, gaa na ụlọ ọgwụ na-ahụ maka ngwa ngwa ma ọ bụ ngalaba mberede ụlọ ọgwụ nwere akara akwụkwọ ndenye ọgwụ gị na akwụkwọ ọgwụ. Rịọ ihe mberede ** ndenye ọgwụ stabilization bridge ma ọ bụ ntụnye akaper ** iji gbochie ọdịdọ mwepu.
4. ** Lezienụ anya maka ihe ịrịba ama ịdọ aka ná ntị nke akwara ozi " tupu ọdịdọ". Gaa na ụlọ mberede ụlọ ọgwụ ozugbo.
5. ** Chebe onye na-ejide onwe ya pụọ ​​​​na ọnyà isi wee tụgharịa ya n'ọnọdụ mgbake.** Kpochapụ ihe ndị siri ike, tinye ohiri isi ma ọ bụ uwe mkpuchi n'okpuru isi, oge ọdịdọ ahụ, etinyela ihe ọ bụla n'ime ọnụ, ma tụgharịa onye ahụ n'akụkụ ya ozugbo nhụsianya kwụsịrị. Lee anyị ọdịdọ enyemaka mbụ ndu.
6. ** Ihuenyo na-arụsi ọrụ ike maka nnukwu Akathisia na nsogbu igbu onwe onye.** Mwepụ benzodiazepine na mberede nwere ike ịkpata akathisia, ahụ mgbakasị akwara dị n'ime na oke ụjọ nke anụ ahụ nke na-ebute mmerụ ahụ n'onwe ya. Ahapụla mmadụ na nnukwu mwepụ benzodiazepine naanị; Ọ bụrụ na echiche igbu onwe ya bilitere, gaa ụlọ ọgwụ ED ma ọ bụ kpọọ 988 (US/Canada Suicide & Crisis Lifeline) ma ọ bụ 111/999 (UK).

Osisi Mkpebi: Ịchọpụta Mbibi Benzodiazepine Na mberede¶

Jiri eserese ngosi ụlọ ọgwụ a mgbe ndenye ọgwụ gwụchara, agbagharaghị ọgwụ, ma ọ bụ mmadụ nwara ịkwụsị benzodiazepines.

flowchart TD
    A["Nkwụsị mberede ma ọ bụ mbelata ngwa ngwa n'iji Benzodiazepine kwa ụbọchị (> Ogologo izu 3 ruo 4)"] --> B{"A na-enweta akara ngosi akwara ozi mberede ugbu a?"}
    B -->|"Ihe ọdịdọ, myoclonic jerking, psychosis/hallucinations, mgbagwoju anya, pulse>115 bpm, ma ọ bụ akathisia igbu onwe."| C["ỌNWỤRỤ NKE ỤMỤ ỤRỤ ỤMỤ ỤMỤ ỤMỤ ỤMỤ ỤMỤ ỤMỤ ỌRỤ: Kpọọ 911/112/999 Ngwa ngwa maka Ụlọ Ọgwụ ED IV/Oral Benzodiazepine Stabilization"]
    B -->|"Onye ọrịa na-amụ anya ma gbakwasara ụkwụ ya, mana ndenye ọgwụ agwụla ma ọ bụ iwepụ nchegbu/ ịma jijiji na-amalite"| D{"Gịnị bụ ike, dose, na ọkara ndụ nke benzodiazepine?"}
    D -->|"Ime mkpụmkpụ ike dị elu (Alprazolam/Xanax, Lorazepam, Triazolam, street Bromazolam) ma ọ bụ nnukwu dose kwa ụbọchị."| E["Ihe ize ndụ ọdịdọ adịte aka (mmalite elekere 12 ruo 48): Gaa na ụlọ ọgwụ ED ma ọ bụ onye na-ede akwụkwọ ngwa ngwa taa na Rx Bottle maka Bridge / Cross-Taper"]
    D -->|"Usoro ọgwụgwọ na-eme ogologo oge (Diazepam/Valium, Chlordiazepoxide, Clonazepam) n'ime awa 24 mbụ."| F["Ihe ize ndụ igbu oge (mmalite ụbọchị 3 ruo ụbọchị 10): Kpọtụrụ dọkịta / onye na-ahụ maka ọgwụ ozugbo ka ịmaliteghachi wee mee atụmatụ ngwa ngwa hyperbolic taper 5-10%."]
    C --> G["Protocol ụlọ ọgwụ: wuliteghachi ebe obibi GABA-A (Diazepam/Lorazepam/Phenobarbital) na mgbanwe iji mee ka onye ọrịa na-arịa ọrịa nwayọ nwayọ."]
    E --> G

Nkebi nke 1: Gịnị kpatara na-eme mkpụmkpụ vs. Benzodiazepines na-eme ogologo oge na-ada na usoro oge dị iche iche¶

N'adịghị ka mmanya na-aba n'anya, nke na-ekpochapụ n'ọbara n'ime awa ma na-akpalite ịwepụ mgbe niile na elekere elekere 6 ruo 96, ** benzodiazepines dịgasị iche site na ihe karịrị okpukpu iri na mkpochapụ ọkara ndụ ha . N'ihi ya, onye na-akwụsị ** alprazolam (Xanax) *** na-adaba n'ime nnukwu nkwụsịtụ n'ime awa 18 ruo 36, ebe onye na-akwụsị ** diazepam (Valium) ma ọ bụ clonazepam (Klonopin) nwere ike ịdị na-adị ya mma maka ụbọchị 3 ma ọ bụ 4 mbụ wee na-ata ahụhụ na mberede na nnukwu ọrịa ike ọgwụgwụ, ụbọchị 1 ma ọ bụ ụbọchị 5.

Pharmacokinetic & Tebụl nha nha: Isi Benzodiazepines na Z-ọgwụ¶

• (Dabere na ** Ashton Manual **, ** American Society of Addiction Medicine / ASAM 2025 Clinical Practice Guideline **, na British National Formulary ; A na-egosi ọnụ ọnụ ọnụ ọnụ nke ** 10 mg nke Diazepam / Valium ** ka ndị ọrịa na ezinụlọ wee ghọta etu siri ike "1 milligram" nke nnukwu benzo.

Nkebi 2: Ịghọta ụyọkọ 3 pụrụ iche nke mwepu Benzodiazepine siri ike.¶

N'ihi na \(\text{GABA}_\text{A}\) na-ekesa ọ bụghị naanị na ụbụrụ mmetụta uche nke ụbụrụ (amygdala), kamakwa n'ime moto cortex, visual / auditory cortex, spinal cord, and gut (enteric nervous system), mwepu benzodiazepine mberede na-emepụta ** dị egwu anụ ahụ na sensory mgbaàmà ** na ọtụtụ ndị ọrịa na-achọpụta ọrịa strok dị ka ndị ọrụ mberede na mberede. vertigo, ma ọ bụ isi psychosis:

1. Ụyọkọ A: Sensory na-akpali akpali & Mgbagwoju anya (Akara ịdọ aka ná ntị tupu ọdịdọ)¶

• Hyperacusis na Photophobia: Olu mkparịta ụka nkịtị, ngwa ọla ọcha na-akpụ akpụ, ma ọ bụ oriọna ime ụlọ na-enwe ahụ mgbu, na-adụpu n'anụ ahụ na ntị na anya.
• Tinnitus na Ọla Ọla: Ụda, ụda na-ada ụda ma ọ bụ na-ebigbọ na ntị ya na uto ọla ma ọ bụ kemịkal dị iche na ire.
• Paresthesias na "Benzo Belly": Ọkụ, tingling, eletriki-ujo sensations ("ụbụrụ zaps"), ntụtụ na agịga na njedebe, na nnukwu eriri afọ ma ọ bụ gastroparesis.
• ** Derealization na Derealization: *** Mmetụta dị egwu dị ka nrọ na ime ụlọ gbara ya gburugburu dị larịị, akụkụ abụọ, ma ọ bụ artificial (* derealization ), ma ọ bụ na onye ahụ na-apụ n'ahụ nke ha ( depersonalization *), na-esonyere ya na-ahụ anya na mgbidi ma ọ bụ ala na-adịghị agwụ agwụ.

2. Ụyọkọ B: Neuromuscular & Autonomic Hyperactivity¶

• Myoclonus na Fasciculations: Ikpuru na-adịghị agwụ agwụ-dị ka ọnyà ma ọ bụ ịkụgharị n'okpuru akpụkpọ nku anya, isi mkpịsị aka, nwa ehi na apata ụkwụ, na-aga n'ihu ruo ** anụ ahụ dum na mberede (myoclonic jerks)** nke na-egosi cortex moto na-eru nso n'ọnụ ụzọ njide ọdịdọ.
• ** Akathisia (Ihe mgbaàmà kacha egbu onwe ya): *** Ọ bụghị naanị "nchegbu," ** akathisia *** bụ ihe na-agaghị ekwe omume, nke na-akpata nhụsianya n'ime ahụ nke kemịkalụ ebe onye ọrịa na-eche na usoro ụjọ ha na-agbanye n'ime oghere eletrik, na-amanye ha ka ha na-agba ọsọ n'ala ruo awa na njedebe na-enweghị ike ịnọdụ ala ma ọ bụ dinara ala maka 10 sekọnd. A ga-amata Akathisia ozugbo dị ka mmetụta na-ewepụ ọgwụ na-ewepụ kama "ime ihe."
• ** Oké ifufe nke akpaaka:** Ụra obi izu ike karịrị 100 ruo 130 iti kwa nkeji, ọbara mgbali elu, ọsụsọ abalị na-eri mmiri, ụmụ akwụkwọ gbawara agbawa, na nnukwu ehighị ụra nke ọma (awa 0 nke ụra abalị 3 ruo 5 n'usoro).

3. Ụyọkọ C: Ihe mberede Neurological na-eyi ndụ egwu (Kpọọ 911 / 112 / 999 ozugbo)¶

• ** Ọdụdọ Tonic-Clonic Achịkọbara & Ọnọdụ Epilepticus:** Nwere ike ime dị ka otu nnukwu mgbakasị ahụ ma ọ bụ ọdịdọ azụ na azụ ugboro ugboro na-enwetaghachighị uche n'etiti ha (** ọnọdụ epilepticus ***), nke na-ebute mmerụ ahụ ụbụrụ hypoxic na-adịgide adịgide ma ọ bụ ọnwụ ma ọ bụrụ na akwụsịghị ya na ọgwụ GABAergic mberede.
• Benzodiazepine Ịhapụ Delirium & Psychosis: Ahụhụ, ịnụ ihe, ma ọ bụ ihe na-adịghị mma jikọtara ya na mgbakasị ahụ, mgbagwoju anya, na ahụ ọkụ (n'ụlọ ọgwụ yiri mmanya Delirium Tremens).
• ** Mwepu Catatonia: ** Ọnọdụ dị ụkọ, siri ike ebe onye ọrịa na-ewepụ ga-ada ogbi kpamkpam, kwụsie ike, na-elegide anya n'obere oghere, kwụsị iri nri ma ọ bụ ị drinkụ mmanya, nke na-agbanwe ngwa ngwa site na intravenous ma ọ bụ sublingual lorazepam.

Nkebi nke 3: Ihe ị ga-eme ma ọ bụrụ na ọgwụ agwụla gị ma ọ bụ ebipụ gị na mberede¶

Ọtụtụ nde ndị ọrịa na-ewere benzodiazepines a na-enye ọgwụ kpọmkwem dị ka a gwara ya ruo ọtụtụ afọ, naanị na-eche nsogbu mberede ihu mgbe ** dọkịta ogologo oge ha lara ezumike nká, ha kwagara steeti ọhụrụ, ụlọ ahịa ọgwụ na-eche ihu azụ azụ azụ, a na-ezu ohi karama pill ha mgbe ha na-eme njem, ma ọ bụ onye na-eweta ọhụrụ jụrụ ịga n'ihu na ndenye ọgwụ.

Soro nke a kpọmkwem ** 4-Nzọụkwụ Atụmatụ Nkwụsi Ike Mberede *** tupu nnukwu mwepu dị elu:

Kwụpụ 1: Lelee ma ọ bụrụ na ụlọ ahịa ọgwụ gị nwere ike ịnye "Nnyefe akwa akwa 72-hour mberede"¶

Ọ bụrụ na ị nwere akụkọ ndenye ndenye ahaziri na agbụ ụlọ ahịa na-ere ahịa na enweghị ike ịnweta dọkịta gị n'ime izu ụka ma ọ bụ ezumike: - Weta karama ndenye aha gị ugbu a (ebe ọ bụ na benzodiazepines bụ ** Nhazi IV ihe ndị a na-achịkwa** na US na ọgwụ ndị a na-achịkwa na UK/Canada/EU, iwu siri ike karịa maka ọgwụ mgbali ọbara, * Otú ọ dị* ọtụtụ ikike na-enye onye na-ere ọgwụ aka ịkpọtụrụ onye na-ahụ maka mkpuchi oku na-akpọ dọkịta nke otu ahụike gị ka ọ nye ikike iweghachi ihe mberede ozugbo 5-3 ụbọchị). - Na **United Kingdom ***, kpọọ NHS 111 ozugbo iji rịọ maka nyocha ọgwụ na-achịkwa ngwa ngwa site na ọrụ GP na-adịghị arụ ọrụ.

Kwụpụ 2: Otu esi ewebata na Ngalaba Mberede ụlọ ọgwụ (Akwụkwọ edemede onye ọrịa kpọmkwem)¶

Ọ bụrụ na ịnweghị ike ịgakwuru onye na-ede akwụkwọ, enweghị ọgwụ, wee malite inwe ịma jijiji, obi ịgba ọsọ, mgbawa akwara, ma ọ bụ ụjọ nlọghachi azụ, ** gaa na ngalaba mberede ụlọ ọgwụ kama ịgagharị ụlọ ọgwụ na-ere ahịa ** (ọtụtụ ụlọ ọgwụ na-ere ahịa ngwa ngwa nwere atumatu ụlọ ọrụ na-amachibido usoro nhazi ihe nchịkwa IV).

Iji zere ịbụ ndị a na-eduhie eduhie na nkewa dị ka "ịchọ ọgwụ," ** weta karama ndenye ọgwụ gị, akụkọ ngwa ụlọ ahịa ọgwụ na-egosi nju gị na-aga n'ihu kwa ọnwa, yana foto ID**, wee jiri edemede nkwurịta okwu a doro anya:

• "Ana m ewere [ezigbo ọgwụ na dose milligram kwa ụbọchị, dịka, Clonazepam 1 mg ugboro abụọ kwa ụbọchị] na-aga n'ihu maka [X ọnwa / afọ] dị ka Dr. [Aha aha] nyere m aka n'ihi na [dọkịta lara ezumike nká / furu efu na njem / ụlọ ọgwụ mechiri], na njedebe ikpeazụ m bụ [X] awa gara aga. M na-enweta nnukwu mgbakasị ahụ, nke gụnyere tachidiazepine, nke na-ewepụ benzochydiazepine. Anaghị m arịọ maka ndenye ọgwụ ogologo oge: Ana m arịọ maka nkwụsi ike ahụike mberede iji gbochie ọdịdọ mwepu benzodiazepine yana atụmatụ akwa akwa / taper dị mma ruo mgbe m ga-ahụ dọkịta ọhụrụ m na-ahụ maka ọpụpụ na [Ụbọchị]."*

Kwụpụ 3: Ihe kpatara ụlọ ọrụ “Rapid Detox” nke ụbọchị 5 ji dị ize ndụ maka ịdabere na Benzodiazepine ogologo oge¶

Ịdọ aka ná ntị ụlọ ọgwụ dị egwu kwadoro ** 2020 FDA Benzodiazepine Boxed Warning **, ** 2025 ASAM Joint Clinical Practice Guideline on Benzodiazepine Tapering *** na ** British National Formulary *: - Edebanyela onye ọrịa benzodiazepine ogologo oge kwa ụbọchị n'ime mmemme oyi-atụ oyi-ụbọchị 5 ruo 7 belụsọ na ha nọ na nnukwu nsogbu ahụike na-eyi ndụ egwu chọrọ ntughari phenobarbital/anticonvulsant. - N'adịghị ka opioids ma ọ bụ mmanya, ebe nnukwu anụ ahụ detox nwere ike mechaa n'ime ụbọchị 5 ruo 10, \(\text{GABA}_\text{A}\) receptor subunits gbanwere site na ọnwa ma ọ bụ afọ nke benzodiazepines kwa ụbọchị na-ewe ọnwa ** ọnwa (ọ bụghị ụbọchị) iji degharịa protein ndị nnabata ọhụrụ wee laghachi na ntọala. - Ịwepụ onye ọrịa afọ 2 nke Klonopin ma ọ bụ Xanax n'ime ụbọchị 5 na ụlọ ọrụ detox azụmahịa na-ezigakarị ha n'ụlọ n'ụbọchị 6 ziri ezi dị ka metabolites na-arụ ọrụ ogologo oge doro anya, na-ebute ** nhụsianya nnukwu ụlọ ọgwụ na ụbọchị 8 ** ma ọ bụ ọnwa nke na-agwụ ike ** Protracted Withdrawal Syndrome (BIND)**.

Nkebi 4: Otu Benzodiazepine Tapering si arụ ọrụ akaebe (Ụzọ Ashton & ASAM)¶

Ozugbo nnukwu nsogbu ndọrọ ndọrọ ọchịchị kwụsiri ike na Ngalaba Mberede ma ọ bụ ụlọ ọgwụ na-apụ apụ site na iweghachi usoro usoro ọgwụgwọ na-aga n'ihu, nkwụsị nke ọma na-esote ** ụkpụrụ ahụike atọ na-egosi ** nke Prọfesọ C. Heather Ashton bụ onye ọsụ ụzọ (* Akwụkwọ ntuziaka Ashton ) ma kwadoro ya ** American Society of Addiction Medicine (ASAM)* na **

1. Ụkpụrụ 1: kwụsie ike na Cross-Taper Site na mkpụmkpụ-eme ihe ruo ogologo oge Diazepam¶

Ịgbalị ịgbanye benzodiazepine dị mkpụmkpụ dị ka alprazolam (Xanax) siri ike nke ukwuu n'ihi na ọkara ndụ ya dị awa 6 ruo 12 na-eme ka ọkwa ọbara onye ọrịa daa ugboro anọ n'ụbọchị (mwepu n'ime doses ), na-ebute oke iwe iwe obere ihe ike n'etiti ọgwụ ọ bụla. - Na mgbakwunye, Xanax na Ativan na-abịa na obere mbadamba mbadamba (mbadamba).0.5 mg, 1 mg, 2 mg) nke a na-apụghị ịbelata ngwa ngwa n'ime obere mbelata pasent 5. - Ya mere, ndị dibịa bekee na-eme ugboro ugboro ** ngbanwe nwayọọ nwayọọ site na ọkwa (cross-taper) na nha nha nke ** ogologo oge Diazepam (Valium)* (ma ọ bụ jiri micro-dosing / ngwakọta nke clonazepam ma ọ bụ lorazepam). N'ihi na diazepam nwere ọkara ndụ metabolite na-arụ ọrụ nke awa 100 ruo 200 ma arụpụtara ya na obere mbadamba 2-milligram, 5-milligram, na 10-milligram mbadamba (yana 1 mg/mL Ngwọta mmiri mmiri ọnụ), ọ na-emepụta "nkwụsị ọbara" dị larịị, kwụ ọtọ ma na-enye ohere mbelata 0.5-milligram na-enweghị mbọ.

2. Ụkpụrụ 2: Mbelata "Hyperbolic" dị nwayọọ, onye ọrịa na-eme ngwa ngwa (5% ruo 10% Kwa izu 2 ruo 4)¶

• ** Ebipụla ya site na nnukwu mkpọ (dị ka "ịbelata 25% kwa izu").** PET-scan receptor occupancy studies show that \(\text{GABA}_\text{A}\) receptor bonding so a hyperbolic curve: nke ikpeazụ 2 milligrams nke diazepam na-enwe ihe na-adịghị mma nke ụbụrụ 1 milligrams nke mbụ.
• Ntuziaka ụlọ ọgwụ ọkọlọtọ na-akwado ibelata ** nke ugbu a site na pasent 5 ruo pasent 10 kwa izu 2 ruo 4, na ịbelata ọbụna n'ihu n'ime nkeji iri na ise ikpeazụ nke taper, ebe ** na-ejide dose ahụ n'otu n'otu ** maka izu ole na ole ọzọ mgbe ọ bụla mgbaàmà nkwụsị na-apụta. Onye ọrịa, ọ bụghị kalenda siri ike, na-edobe ọsọ nke taper.

3. Nleba anya nke ogbo site na ọkwa & Ihe ngosi Hyperbolic Taper¶

Iji ghọta otú dọkịta na-ahụ maka ọgwụ riri ahụ ma ọ bụ onye isi mgbaka si ewepụ onye ọrịa n'enweghị nsogbu na benzodiazepine na-eme mkpụmkpụ na-enweghị ịkpalite nkwụsị ma ọ bụ ọdịdọ, lelee ka ** Ashton Cross-Taper ** si agbanwe ** 1.5 mg kwa ụbọchị nke Alprazolam (Xanax)** (a na-ewere dị ka 0.5 mg n'ụtụtụ, 0.5 mg ruo etiti ụbọchị, 0.5 mg. mg nke Diazepam / Valium ***) na diazepam tupu ịpịa:

4. Ndị Pụrụ Iche Ndị Nwere Ihe ize ndụ: Ndị Okenye, Ime Ime, na Ndị Ngwọta Agwakọtara¶

Ụfọdụ ndị mmadụ na-eche ihe egwu ahụike pụrụ iche ihu n'oge nkwụsị benzodiazepine ma chọọ nlekọta dọkịta pụrụ iche:

1. ** Okenye (afọ 65 na okenye):**
   • Site na ịka nká, imeju cytochrome P450 enzyme ọrụ na-ebelata na pasent abụba anụ ahụ na-abawanye, na-agbatị nkwụsị ọkara ndụ diazepam na chlordiazepoxide site na awa 40 ruo ** ihe karịrị awa 150 ruo 200 **.
   • N'ime ndị toro eto, mwepu benzodiazepine na mberede na-egosikarị ọ bụghị dị ka "ụjọ," kama dị ka ** nnukwu ụdị ụlọ ọgwụ delirium, ọdịda mberede, ọhụụ anya, ma ọ bụ mgbagwoju anya dịka ọrịa strok ** malite ụbọchị 5 ruo 10 mgbe mgbanwe dose gasịrị. N'aka nke ọzọ, mgbe ị na-agafe okenye okenye, ndị dọkịta na-ahọrọkarị obere doses ** lorazepam ma ọ bụ oxazepam ** (ma ọ bụ jiri nlezianya belata doses diazepam) iji zere ịrapara n'ehihie na mgbaji hip-ada.
2. ** Ime na ọpụpụ nwa ọhụrụ:**
   • Ịkwụsị benzodiazepine kwa ụbọchị n'oge ime ime bụ nke a egbochighị ya nke ọma n'ihi na nkwụsị nke nne na-akpata nnukwu ** nwa ebu n'afọ hypoxia, mwepu placental, ma ọ bụ ime ọpụpụ/ime ime tupu oge eruo**. Ndị ọrịa dị ime kwesịrị ka onye dibia bekee na onye dibịa bekee na-elekọta ya site na iji usoro nkwụsi ike kacha dị ala ma ọ bụ nwayọ, na-enyocha taper trimester.
3. ** Mmanya ma ọ bụ Opioid na-emekọ ọnụ:**
   • Ọ bụrụ na onye ọrịa dabere na ma ** opioids na benzodiazepines ***, Ntuziaka ** 2020 FDA ** na ** ASAM Ntuziaka *** na-emesi ike na ndị na-ede akwụkwọ ** agaghị ebipụ ọgwụ benzodiazepine ogologo oge nke onye ọrịa na mberede naanị n'ihi na onye ọrịa na-amalite Buprenorphine (Suboxone) ma ọ bụ Methadone abrupt, dị ka ihe na-akpalite abrupt. ọdịdọ ma na-ebuga ndị ọrịa laghachi na ọgwụ fentanyl/n'okporo ụzọ.

5. Ụkpụrụ 3: Ọgwụ ndị a ga-ezere n'oge mwepụ nke Benzodiazepine¶

A ga-ezere ụfọdụ ọgwụ ndị a na-ahụkarị ** n'oge mwepu benzodiazepine siri ike ma ọ bụ tapering n'ihi na ha na-emegide \(\text{GABA}_\text{A}\) ndị na-anabata ya ma ọ bụ wedata ọnụ ụzọ ọdịdọ:

Ajụjụ a na-ajụkarị¶

enyochara isi mmalite¶

• ** American Society of Addiction Medicine (ASAM) & nine partnering medical societies (2025): *** Joint Clinical Practice Guideline on Benzodiazepine Tapering * (Ntụle ihe ize ndụ, usoro mbelata dose hyperbolic, cross-tapering to long-acting formulations, and inpatient vs. outpatient care).
• ** Nchịkwa nri na ọgwụ ọjọọ nke United States (FDA): *** * Nkwukọrịta nchekwa nchekwa ọgwụ FDA: A na-emelite ịdọ aka ná ntị igbe iji meziwanye ojiji nke klaasị ọgwụ Benzodiazepine (ihe ize ndụ nke ịdabere n'anụ ahụ, nkwụsị nke nkwụsị na-eyi ndụ egwu site na nkwụsị ngwa ngwa, yana ọrịa nkwụsị ogologo oge).
• ** Ashton, C. Heather (Newcastle University Institute of Neuroscience, United Kingdom): *** Benzodiazepines: Otu Ha si arụ ọrụ na otu esi eweghachi (Akwụkwọ ntuziaka Ashton)*, na-ekpuchi tebụl nha anya diazepam, ụkpụrụ nnọchi nwayọ nwayọ, na njikwa ụlọ ọgwụ nke nnukwu mgbagha mgbagha na ogologo oge.
• ** National Institute for Health and Care Excellence (NICE) na British National Formulary (BNF, United Kingdom):*** Ọgwụ ejikọtara na Ndabere ma ọ bụ Mgbapụta Mwepu: Nchekwa Nkọwapụta na Mwepụ maka Ndị okenye (NG214)*.
• ** Òtù Ahụ Ike Ụwa (WHO):** * Ntuziaka ụlọ ọgwụ maka njikwa ịwepụ na ọgwụgwọ nke ịdabere na ọgwụ ọjọọ* (Sedative-hypnotic withdrawal seizure prophylaxis na delirium management).

Ntuziaka emetụtara¶

• Iji ihe na ọgwụ riri ahụ: ntuziaka enyemaka mberede
• Mwepụ mmanya na-egbu egbu, Delirium Tremens (DTs), na nhụsianya detox nke ahụike
• Ihe ize ndụ ịdoụbiga mmanya ókè, xylazine, na naloxone nlọghachite nlọghachi azụ mgbe nnabata gasịrị
• Ịkwado onye òtù ezinụlọ na-eri ahụ
• Ọdụdọ enyemaka mbụ
• Mwakpo ụjọ
• Nsogbu ahụike uche
• Nọmba mberede